Early intervention with secukinumab prevents epigenetic scar development in new-onset psoriasis – STEPIn Mechanistic Sub-study results

Journal:

The Journal of Allergy and Clinical Immunology

Published:

2026-05-25

DOI:

10.1016/j.jaci.2026.04.028

Affiliations:

7

Authors:

18

Go to article

Institutions	Authors	Share
Novartis Biomedical Research, Switzerland	7.500000	0.42
University of Michigan (U-M), United States of America (USA)	5.000000	0.28
Novartis, Switzerland	1.500000	0.08
Karolinska Institute (KI), Sweden	1.500000	0.08
Aarhus University Hospital, Denmark	1.000000	0.06
University Hospital of Lausanne (CHUV), UNIL, Switzerland	1.000000	0.06
Karolinska University Hospital, Sweden	0.500000	0.03

Interested in Clinical Sciences?